Want to see HK:0911 full AI Analyst Report?
Qianhai Health Holdings Ltd. (0911) Ratios
Qianhai Health Holdings Ltd. Ratios
HK:0911's free cash flow for Q2 2026 was $-43.18M. For the 2026 fiscal year, HK:0911's free cash flow was increased by $0.00 and operating cash flow was $-43.18M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 22.62 | 18.12 | 4.80 | 5.20 | 10.14 |
| Quick Ratio | 16.58 | 5.95 | 4.80 | 0.23 | 3.08 |
| Cash Ratio | 3.57 | 1.09 | 0.21 | 0.02 | 0.04 |
| Solvency Ratio | 0.43 | 0.14 | -0.53 | -2.37 | 0.02 |
| Operating Cash Flow Ratio | 2.26 | 0.20 | 0.01 | -0.05 | -0.65 |
| Short-Term Operating Cash Flow Coverage | 91.50 | 0.00 | 0.00 | -7.51 | -6.17 |
| Net Current Asset Value | $ 371.55M | $ 364.42M | $ 357.65M | $ 407.81M | $ 622.45M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.04 | 1.06 | 1.24 | 1.22 | 1.10 |
| Debt Service Coverage Ratio | 15.55 | 680.09 | -1168.12 | -285.13 | 0.27 |
| Interest Coverage Ratio | 149.16 | 605.17 | -1225.70 | -4821.91 | -31.60 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.06 |
| Interest Debt Per Share | 0.00 | 0.01 | 0.00 | 0.01 | 0.05 |
| Net Debt to EBITDA | -8.48 | -1.42 | 0.38 | 0.00 | 2.61 |
| Profitability Margins | |||||
| Gross Profit Margin | 3.29% | 5.71% | -3.70% | 3.90% | 5.66% |
| EBIT Margin | 0.84% | 2.68% | -5.48% | -11.91% | -0.13% |
| EBITDA Margin | 1.06% | 3.01% | -5.23% | -11.79% | 0.73% |
| Operating Profit Margin | 0.84% | 2.68% | -5.48% | -8.36% | -5.67% |
| Pretax Profit Margin | 0.88% | 0.25% | -5.48% | -11.91% | -0.31% |
| Net Profit Margin | 0.88% | 0.25% | -5.48% | -11.91% | -0.31% |
| Continuous Operations Profit Margin | 0.88% | 0.25% | -5.48% | -11.91% | -0.31% |
| Net Income Per EBT | 99.97% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 104.85% | 9.42% | 100.00% | 142.55% | 5.53% |
| Return on Assets (ROA) | 1.45% | 0.32% | -11.02% | -43.73% | -0.12% |
| Return on Equity (ROE) | 1.52% | 0.34% | -13.72% | -53.52% | -0.13% |
| Return on Capital Employed (ROCE) | 1.45% | 3.61% | -13.72% | -37.50% | -2.39% |
| Return on Invested Capital (ROIC) | 1.45% | 3.60% | -13.70% | -33.87% | -2.37% |
| Return on Tangible Assets | 1.45% | 0.32% | -11.02% | -43.73% | -0.12% |
| Earnings Yield | 12.75% | 2.71% | -8.19% | -156.73% | -0.70% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.04 | 5.26 | 5654.65 | 96.16 | 1.37 |
| Payables Turnover | 42.06 | 0.00 | 5864.08 | 92.41 | 5.30 |
| Inventory Turnover | 6.30 | 1.89 | 0.00 | 3.90 | 0.56 |
| Fixed Asset Turnover | 34.46 | 24.57 | 36.32 | 67.88 | 9.42 |
| Asset Turnover | 1.66 | 1.28 | 2.01 | 3.67 | 0.38 |
| Working Capital Turnover Ratio | 1.84 | 1.44 | 2.51 | 3.81 | 0.51 |
| Cash Conversion Cycle | 169.38 | 262.51 | 0.00 | 93.41 | 853.67 |
| Days of Sales Outstanding | 120.16 | 69.35 | 0.06 | 3.80 | 266.54 |
| Days of Inventory Outstanding | 57.90 | 193.16 | 0.00 | 93.56 | 656.00 |
| Days of Payables Outstanding | 8.68 | 0.00 | 0.06 | 3.95 | 68.86 |
| Operating Cycle | 178.06 | 262.51 | 0.06 | 97.36 | 922.53 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.23 | 0.02 | 0.00 | -0.03 | -0.26 |
| Free Cash Flow Per Share | 0.23 | 0.02 | 0.00 | -0.03 | -0.26 |
| Dividend Paid and CapEx Coverage Ratio | 2771.14 | 599.86 | 0.00 | -1314.25 | -4908.56 |
| Capital Expenditure Coverage Ratio | 2771.14 | 599.86 | 0.00 | -1314.25 | -4908.56 |
| Operating Cash Flow Coverage Ratio | 91.50 | 4.06 | 1.76 | -4.43 | -5.64 |
| Operating Cash Flow to Sales Ratio | 0.06 | 0.01 | 0.00 | -0.00 | -0.16 |
| Free Cash Flow Yield | 83.23% | 8.68% | 0.13% | -3.53% | -34.80% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 7.83 | 36.84 | -12.22 | -0.64 | -142.99 |
| Price-to-Sales (P/S) Ratio | 0.07 | 0.09 | 0.67 | 0.08 | 0.45 |
| Price-to-Book (P/B) Ratio | 0.12 | 0.13 | 1.68 | 0.34 | 0.19 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 1.20 | 11.52 | 751.33 | -28.34 | -2.87 |
| Price-to-Operating Cash Flow Ratio | 1.20 | 11.50 | 751.33 | -28.37 | -2.87 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | -0.30 | 0.12 | -0.00 | -13.44 |
| Enterprise Value Multiple | -2.00 | 1.67 | -12.44 | -0.64 | 64.37 |
| Enterprise Value | -14.36M | 26.07M | 624.85M | 148.66M | 132.34M |
| EV to EBITDA | -2.00 | 1.67 | -12.44 | -0.64 | 64.37 |
| EV to Sales | -0.02 | 0.05 | 0.65 | 0.08 | 0.47 |
| EV to Free Cash Flow | -0.37 | 6.22 | 729.12 | -28.26 | -2.99 |
| EV to Operating Cash Flow | -0.37 | 6.21 | 729.12 | -28.28 | -3.00 |
| Tangible Book Value Per Share | 2.31 | 2.28 | 0.23 | 2.58 | 3.96 |
| Shareholders’ Equity Per Share | 2.31 | 2.28 | 0.23 | 2.58 | 3.96 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.09 | 0.00 |
| Revenue Per Share | 4.00 | 3.07 | 0.57 | 11.58 | 1.67 |
| Net Income Per Share | 0.04 | 0.01 | -0.03 | -1.38 | -0.01 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.05 | 0.09 | 1.00 | 1.00 | 2.34 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.02 | 0.03 | 0.02 | 0.01 | 0.07 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 6.53 | 3.20 | -0.02 | 0.02 | 49.75 |
Currency in HKD
